Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene ExpressionDavid A. Jacobsohn, Michael A. Pulsipher, Amy K. Keating et al.|Transplantation and Cellular Therapy|2018Cited by 44
LNK/<i>SH2B3</i> as a novel driver in juvenile myelomonocytic leukemiaAstrid Wintering, Elliot Stieglitz, Anna Hecht et al.|Haematologica|2023Cited by 8
Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopeniaRoshini S. Abraham, Donald B. Kohn, Amrita Basu et al.|Clinical Immunology|2024Cited by 8
Outcomes Following Matched Sibling Donor Transplant for Severe Combined Immunodeficiency: A Report from the PidtcAhmad Rayes, Christopher C. Dvorak, Brent R. Logan et al.|Transplantation and Cellular Therapy|2024Cited by 3
Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTCAhmad Rayes, Jennifer Heimall, Brent R. Logan et al.|Blood Advances|2025Cited by 0